MedicaidPrior AuthMedium impact
Asparlas™ (calaspargase pegol-mknl) (Revised)
Humana·IN · Oncology, Pediatrics·Medicaid
We identified it
Jul 21, 2026
Summary
This is a revised Prior Authorization policy for Asparlas™ (calaspargase pegol-mknl) affecting Medicaid Indiana members. The policy update requires billing and clinical teams to verify current authorization requirements before submitting claims for this specialty oncology drug.
Action Required
Immediately: Billing team must access the full policy document at https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a584854 to review revised prior authorization requirements for Asparlas™ (HCPCS code J9041). Update clinical and billing workflows to reflect any new authorization procedures. Providers must obtain prior authorization before administering Asparlas™ to Indiana Medicaid members. Ensure all claims submissions include required prior authorization documentation. Failure to obtain prior authorization will result in claim denials and delayed reimbursement.